India’s Intellectual Property Appellate Board is hearing Bayer’s appeal to the government’s compulsory license for patents on the drug Sorafenib (sold under the brand name Nexavar by Bayer). This medicine is used to treat kidney and liver cancer. The branded…
Press Release by the Campaign for Affordable Trastuzumab CONTACT: Kalyani Menon-Sen: +91 9910306382, kmenonsen[at] gmail.com Leena Menghaney: +91 9811365412, leenamenghaney [at] gmail.com The Campaign for Affordable Trastuzumab welcomes the news that the Government of India has started the process of issuing…
[Reposted with permission from citizen.org] November 10, 2012 marked the first anniversary of the global Kaletra campaign, a campaign comprising health groups in 12 countries challenging pharmaceutical monopolies including Abbott Laboratories’ hold on HIV/AIDS treatment Kaletra and its components lopinavir…
It is a tremendous victory for people living with HIV in Indonesia that it has issued new compulsory licenses on seven anti-retroviral medicines, allowing the government to access generic versions of those medicines – domestically or by importation – at…
The Ugandan Center for Health Human Rights and Development has published a set of Model Provisions to Promote Access to Affordable Medicines in the country’s IP legislation that has been under debate for three years. The project was done with…
Precedent-Setting Government Order has Extraordinary Lifesaving Potential On September 3, the government of Indonesia took a quiet but exceptionally important step to expand access to medicines and help save and improve lives of people living with HIV/AIDS and hepatitis B.…
This blog is a summary of a panel titled “The Future of Affordable Antiretroviral Treatment: Trends in Patents and Price” at the XIX International AIDS Conference in Washington, DC on July 25, 2012. The authors’ presentations are available on a…
In testimony before the U.S. House of Representatives Subcommittee on Intellectual Property, Competition and the Internet on 27 June 2012 (Hearing: Protecting Patents, Trade Secrets, and Market Access), the Deputy Director of the U.S. Patent and Trademark Office, who also serves…
The UN Development Programme and UNAIDS released a joint policy brief this week at workshop on the “Use of TRIPS Flexibilities and Access to Affordable ARVs in Asia.” The paper notes that the use of TRIPS flexibilities has expanded the…
[Reposted from CIS-India.org] There are some welcome provisions in the Copyright (Amendment) Bill 2012, and some worrisome provisions. Pranesh Prakash examines five positive changes, four negative ones, and notes the several missed opportunities. The larger concern, though, is that many…
Just as Novartis appealed from an order denying its patent application on Glivec, Bayer has now appealed the granting of a compulsory license on Nexavar. Rather than honestly state that it likes selling its cancer medicines for $67,000 to only…
Both sides appeal in ongoing civil society lawsuit for compulsory license A Colombian administrative judge has ruled that Abbott Laboratories and the Ministry of Health threatened and violated collective rights to public health by maintaining the price of an HIV…